- Home
- BZUN vs ARCT Comparison
BZUN vs ARCT Comparison
Compare BZUN & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZUN | ARCT |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.5M | 293.9M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BZUN | ARCT |
|---|---|---|
| Price | $3.59 | $10.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | $4.58 | ★ $23.80 |
| AVG Volume (30 Days) | 369.5K | ★ 627.1K |
| Earning Date | 11-24-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | $8.08 | N/A |
| Revenue Next Year | $7.45 | $64.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.07 | $5.50 |
| 52 Week High | $3.92 | $17.96 |
Technical Indicators
Market Signals| Indicator | BZUN | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.47 | 35.74 |
| Support Level | $2.57 | $6.53 |
| Resistance Level | $3.59 | $17.85 |
| Average True Range (ATR) | 0.22 | 1.00 |
| MACD | 0.00 | -0.26 |
| Stochastic Oscillator | 54.73 | 2.38 |
Price Performance
Historical ComparisonAbout BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.